MedTrace Logo

Improving Treatment Adherence in HIV-Infected Individuals

NCT00247611 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 594

Last updated 2013-12-20

Study results available
· View outcomes & findings →

Summary

This study will develop and evaluate the efficacy of an individualized, interactive, computer software program delivered in conjunction with clinical care in increasing and supporting antiretroviral therapy adherence in HIV-infected individuals.

Conditions

  • HIV Antiretroviral Therapy (ART) Adherence
  • Health Behavior

Interventions

BEHAVIORAL

LifeWindows Intervention Sessions

At each clinical care visit, intervention arm participants use the full LifeWindows program, which includes welcome and assessment surveys and also includes the active intervention modules. ART adherence promotion intervention activities are tailored to the participant's assessment responses. Participants select which activities he or she wishes to use which culminates in an adherence specific goal.

OTHER

Control

At each clinical care visit, control arm participants use the portion of the LifeWindows software program that provides a welcome from the avatar and collection of assessment items/surveys.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • University of Connecticut

    lead OTHER

Principal Investigators

  • Jeffrey D. Fisher, PhD · University of Connecticut

  • K. Rivet Amico*, PhD · University of Connecticut (*co-PI)

  • Deborah H. Cornman*, PhD · University of Connecticut (*co-PI)

  • William A. Fisher*, PhD · University of Western Ontario (*co-PI)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00247611 on ClinicalTrials.gov